Skip to main content
SpringerLink
Log in

Antitussiva und Expektorantien

  • Chapter
Arzneiverordnungs-Report 2016

  • 2080 Accesses

Zusammenfassung

Seit 1995 sind die Verordnungen der Antitussiva und der Expektorantien stark zurückgegangen. Hauptgrund des rückläufigen Trends ist die zweifelhafte Wirksamkeit dieser Substanzen. Auch der Ausschluss rezeptfreier Arzneimittel aus der Erstattung hat die Abnahme des Verordnungsvolumens seit 2004 weiter beschleunigt. Im Jahre 2015 ist – wenn auch auf niedrigem Niveau – erstaunlicherweise eine Zunahme der Verordnungen festzustellen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Academy of Pediatrics Committee on Drugs (1997): Use of codeine- and extromethorphan-containing cough remedies in children. Pediatrics 99: 918–920

    Article  Google Scholar 

  • Bundesgesundheitsamt (1981): Monographieentwürfe für anthroposophische und phytotherapeutische Arzneimittel. Dtsch Apoth Ztg 52: 2910–2913

    Google Scholar 

  • Cegla UH (1988): Langzeittherapie über 2 Jahre mit Ambroxol (Mucosolvan) Retardkapseln bei Patienten mit chronischer Bronchitis. Ergebnisse einer Doppelblindstudie an 180 Patienten. Prax Klin Pneumol 42: 715–721

    CAS  PubMed  Google Scholar 

  • Celli BR, Decramer M, Wedzicha JA, Wilson KC, Augusti A, et al. (2015). An official Ameriocan Thoracis Society/European Respiratory Society statement: reseach questions in COPD. Eur Respir J 45:879–905

    Article  PubMed  Google Scholar 

  • Cwientzek U, Ottillinger B, Arenberger P (2011): Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine 18: 1105–1109

    Article  PubMed  Google Scholar 

  • Dicpinigaitis PV, Morice AH, Birrung SS, McGarvey L, Smith JA, Canning BJ, Page CP (2014): Antitussive drugs—past, present, and future. Pharmacol Rev 66: 468–512

    Article  CAS  PubMed  Google Scholar 

  • European Medicines Agency (2011): Community herbal monograph on Hedera helix L., folium. Final assessment report on Hedera helix L., folium. Internet: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/herbal/medicines/herbal_med_000115.jsp&mid=WC0b01ac058001fa1d

  • European Medicines Agency (2012): Opinion of the HMPC on a community herbal monograph on Hedera helix L., folium. Internet: http://www.ema-europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_opinion_on_Community_herbal_monograph/2012/01/WC500120649.pdf

  • European Medicines Agency (2015): Ambroxol and bromhexine expectorants: safety information to be updated. Press Release 25. February EMA/130676/2015 Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010: Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org

  • Guyatt GH, Townsend M, Kazim F, Newhouse MT (1987): A controlled trial of ambroxol in chronic bronchitis. Chest 92: 618–620

    Article  CAS  PubMed  Google Scholar 

  • Jones AP, Wallis C (2010): Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010 Mar 17; (3):CD001127

    Google Scholar 

  • Kayser O, Kolodziej H (1997): Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme. Planta Med 63: 508–510

    Article  CAS  PubMed  Google Scholar 

  • Kurz H (1986): Expektorantien und Antitussiva. Dtsch Apoth Ztg 126: 1024–1029

    Google Scholar 

  • Lazaryan M, Shasha-Zigelman C, Dagan Z, Berkovitch M (2015): Codeine should not be prescribed for breastfeeding mothers or children under the age of 12. Act Paediatr 104:555–556

    Google Scholar 

  • Malerba M, Ponticiello A, Radaeli A, Bensi G, Grassi V (2004): Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomised, mulicenter, placebo-controlled study (the AMETHIST Trial). Pulm Pharmacol Therpeut 17: 27–34

    CAS  Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Menzel S, Ruth P (2013): Arzneimittelwirkungen, 10. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart, S. 581–582

    Google Scholar 

  • Müller S, Jaffan L, Kloiber E, Läer S (2014): Dextrometorphan-Missbrauch bei Jugendlichen: Wie kann sich der Apotheker verhalten? Med Mo Pharm 37: 95–100

    Google Scholar 

  • Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh E.E. (2014): Honey for acute cough in children. Cochrane Database Syst Rev Dec 13;12:CD 007094

    Google Scholar 

  • Olivieri D, Zavattini G, Tomasini G (1987): Ambroxol for the prevention of chronic bronchitis exacerbations: longterm multicenter trial. Respiration 51: Suppl 1, 42–51

    Article  PubMed  Google Scholar 

  • Olsson B, Johansson M, Gabrielsson J, Bolme P (1988): Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34: 77–82

    Article  CAS  PubMed  Google Scholar 

  • Øymar K, Skjerven HO, Mikalsen IB (2014): Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med 22: 23

    Article  PubMed  PubMed Central  Google Scholar 

  • Poole P, Black PN, Cates CJ. (2012): Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 15: 8: CD001287

    Google Scholar 

  • Schmidt M, Thomsen M, Schmidt U (2012): Suitability of ivy extract for the treatment of paediatric cough. Phytother Res 26: 1942–1947

    Article  CAS  PubMed  Google Scholar 

  • Sharfstein JM, North M, Serwint JR (2007): Over the counter but no longer under the radar—pediatric cough and cold medications. N Engl J Med 357: 2321–2324

    Article  CAS  PubMed  Google Scholar 

  • Smith SM, Schroeder K, Fahey T (2014): Over-the-counter (OTC) medications for acute cough in children and adults in communitty settings. Cochrane Database Syst Rev Nov 24,11:CD0011831

    Google Scholar 

  • Stauss-Grabo M, Atiye S, Warnke A, Wedemeyer RS, Donath F, Blume HH. (2010): Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan® Cough Tablets) in the treatment of colds accompanied by coughing. Phytomedicine. 15: 433–436

    Google Scholar 

  • Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV (2013): Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013 Oct 22;10:CD006323

    PubMed  Google Scholar 

  • Tse HN, Raiteri L, Wong KY, Yee KS, Wai KY, Loo CK, Houng CM. (2013): High-Dose N-acetylcysteine in stable chronic obstructive pulmonary disease: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest 144: 106–118

    Article  CAS  PubMed  Google Scholar 

  • Virchow JC, Backer V, de Blay F, Kuna P, Ljørring C, Prieto JL, Villesen HH (2015): Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement. Resp Med 109: 547–556

    Google Scholar 

  • Wark P, McDonald VM (2009): Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009 Apr 15; (2): CD001506

    Google Scholar 

  • Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP (2013): Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2013 Jul 31; 7: CD006458

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Maybachstraße 14–16, 68169, Mannheim

    Prof. Dr. med. Dr. h.c. Björn Lemmer

Authors
  1. Prof. Dr. med. Dr. h.c. Björn Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lemmer, B. (2016). Antitussiva und Expektorantien. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2016. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50351-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50351-5_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50350-8

  • Online ISBN: 978-3-662-50351-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation